 Daniel Vargas
Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diagnostic Imaging | 4 | 2020 | 290 | 1.180 |
Why?
| | Aortic Coarctation | 2 | 2020 | 69 | 0.810 |
Why?
| | Computed Tomography Angiography | 3 | 2022 | 99 | 0.570 |
Why?
| | Magnetic Resonance Imaging | 9 | 2023 | 3053 | 0.560 |
Why?
| | Mediastinal Diseases | 1 | 2015 | 10 | 0.520 |
Why?
| | Coronary Vessel Anomalies | 1 | 2016 | 30 | 0.520 |
Why?
| | Aorta | 4 | 2020 | 390 | 0.510 |
Why?
| | Tomography, X-Ray Computed | 7 | 2018 | 2326 | 0.500 |
Why?
| | Cysts | 1 | 2015 | 93 | 0.490 |
Why?
| | Coronary Angiography | 2 | 2021 | 306 | 0.480 |
Why?
| | Coronary Vessels | 1 | 2016 | 230 | 0.450 |
Why?
| | Cardiovascular Diseases | 3 | 2018 | 1729 | 0.430 |
Why?
| | Vascular Stiffness | 3 | 2023 | 408 | 0.380 |
Why?
| | Aortitis | 1 | 2011 | 7 | 0.380 |
Why?
| | Aortography | 1 | 2011 | 50 | 0.370 |
Why?
| | Practice Guidelines as Topic | 2 | 2015 | 1400 | 0.350 |
Why?
| | Angiography | 1 | 2011 | 176 | 0.350 |
Why?
| | Postoperative Complications | 2 | 2020 | 2133 | 0.350 |
Why?
| | Image Enhancement | 1 | 2011 | 162 | 0.340 |
Why?
| | Cocaine-Related Disorders | 2 | 2008 | 107 | 0.340 |
Why?
| | Quality Improvement | 1 | 2014 | 954 | 0.280 |
Why?
| | Magnetic Resonance Imaging, Cine | 2 | 2017 | 174 | 0.250 |
Why?
| | Radiology | 3 | 2015 | 193 | 0.250 |
Why?
| | Echocardiography | 3 | 2022 | 555 | 0.230 |
Why?
| | Heart Aneurysm | 1 | 2019 | 8 | 0.170 |
Why?
| | Chagas Cardiomyopathy | 1 | 2019 | 22 | 0.170 |
Why?
| | Aneurysm, False | 1 | 2019 | 45 | 0.160 |
Why?
| | Heart | 3 | 2021 | 609 | 0.160 |
Why?
| | Predictive Value of Tests | 3 | 2023 | 1801 | 0.160 |
Why?
| | Thoracic Diseases | 1 | 2018 | 13 | 0.160 |
Why?
| | Clinical Competence | 2 | 2015 | 901 | 0.150 |
Why?
| | Cardiac Surgical Procedures | 1 | 2022 | 414 | 0.150 |
Why?
| | Dyspnea | 1 | 2019 | 218 | 0.150 |
Why?
| | Vasculitis | 1 | 2018 | 71 | 0.150 |
Why?
| | Humans | 24 | 2023 | 114937 | 0.150 |
Why?
| | Coronary Artery Disease | 2 | 2021 | 607 | 0.150 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2018 | 76 | 0.140 |
Why?
| | Heart Ventricles | 2 | 2019 | 711 | 0.140 |
Why?
| | Diagnosis, Differential | 3 | 2016 | 1355 | 0.140 |
Why?
| | Arteries | 1 | 2018 | 247 | 0.130 |
Why?
| | Cardiomyopathy, Hypertrophic, Familial | 1 | 2016 | 16 | 0.130 |
Why?
| | Cardiac-Gated Imaging Techniques | 1 | 2016 | 16 | 0.130 |
Why?
| | Multidetector Computed Tomography | 1 | 2016 | 27 | 0.130 |
Why?
| | Radiology Department, Hospital | 1 | 2015 | 18 | 0.130 |
Why?
| | Incidental Findings | 1 | 2016 | 77 | 0.130 |
Why?
| | Pulmonary Valve | 1 | 2017 | 88 | 0.130 |
Why?
| | Heart Atria | 1 | 2016 | 110 | 0.120 |
Why?
| | Pneumonia, Bacterial | 1 | 2016 | 106 | 0.120 |
Why?
| | Hypertension, Pulmonary | 2 | 2023 | 1737 | 0.120 |
Why?
| | Pneumonectomy | 1 | 2016 | 125 | 0.120 |
Why?
| | Epinephrine | 1 | 2015 | 167 | 0.120 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2017 | 175 | 0.120 |
Why?
| | Accreditation | 1 | 2014 | 78 | 0.120 |
Why?
| | Tendons | 1 | 2015 | 120 | 0.120 |
Why?
| | Radiography, Thoracic | 1 | 2015 | 162 | 0.110 |
Why?
| | Brain Diseases | 2 | 2005 | 125 | 0.110 |
Why?
| | Biological Science Disciplines | 1 | 2013 | 16 | 0.110 |
Why?
| | Education, Graduate | 1 | 2013 | 30 | 0.110 |
Why?
| | Pericardium | 1 | 2013 | 49 | 0.110 |
Why?
| | Heart Neoplasms | 1 | 2013 | 49 | 0.110 |
Why?
| | Anaphylaxis | 1 | 2015 | 148 | 0.110 |
Why?
| | Interprofessional Relations | 1 | 2015 | 251 | 0.110 |
Why?
| | Emergency Medicine | 1 | 2015 | 220 | 0.100 |
Why?
| | Rhenium | 1 | 2012 | 4 | 0.100 |
Why?
| | Radioisotopes | 1 | 2012 | 28 | 0.100 |
Why?
| | Decision Support Systems, Clinical | 1 | 2014 | 177 | 0.100 |
Why?
| | Follow-Up Studies | 1 | 2020 | 4427 | 0.100 |
Why?
| | Internship and Residency | 2 | 2013 | 944 | 0.100 |
Why?
| | Brachytherapy | 1 | 2012 | 104 | 0.090 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2016 | 336 | 0.090 |
Why?
| | Referral and Consultation | 1 | 2015 | 634 | 0.090 |
Why?
| | Cardiomyopathies | 2 | 2016 | 300 | 0.090 |
Why?
| | Glioblastoma | 1 | 2012 | 253 | 0.080 |
Why?
| | Sternum | 1 | 2009 | 17 | 0.080 |
Why?
| | Sternoclavicular Joint | 1 | 2009 | 9 | 0.080 |
Why?
| | Program Evaluation | 1 | 2013 | 824 | 0.080 |
Why?
| | Health Services Accessibility | 1 | 2015 | 765 | 0.080 |
Why?
| | Glioma | 1 | 2012 | 296 | 0.080 |
Why?
| | Attitude of Health Personnel | 1 | 2015 | 978 | 0.080 |
Why?
| | Aortic Aneurysm | 1 | 2008 | 56 | 0.070 |
Why?
| | Curriculum | 1 | 2013 | 845 | 0.070 |
Why?
| | Pulse Wave Analysis | 2 | 2018 | 208 | 0.070 |
Why?
| | Myocarditis | 1 | 2008 | 93 | 0.070 |
Why?
| | Substance-Related Disorders | 2 | 2005 | 946 | 0.070 |
Why?
| | Myocardial Ischemia | 1 | 2008 | 234 | 0.070 |
Why?
| | Anti-Bacterial Agents | 1 | 2016 | 1477 | 0.070 |
Why?
| | Treatment Outcome | 1 | 2020 | 9105 | 0.070 |
Why?
| | Muscle, Skeletal | 1 | 2015 | 1472 | 0.070 |
Why?
| | Radiography | 1 | 2008 | 819 | 0.060 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2005 | 10 | 0.060 |
Why?
| | Tomography, Emission-Computed | 1 | 2005 | 58 | 0.060 |
Why?
| | Female | 8 | 2018 | 59581 | 0.060 |
Why?
| | Quality of Life | 1 | 2016 | 2359 | 0.060 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2005 | 77 | 0.060 |
Why?
| | Solvents | 1 | 2005 | 105 | 0.060 |
Why?
| | Adult | 4 | 2017 | 30608 | 0.060 |
Why?
| | Central Nervous System Diseases | 1 | 2005 | 61 | 0.060 |
Why?
| | Brain Neoplasms | 1 | 2012 | 987 | 0.060 |
Why?
| | Hallucinogens | 1 | 2005 | 73 | 0.060 |
Why?
| | Education, Medical, Graduate | 1 | 2007 | 374 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2015 | 2223 | 0.050 |
Why?
| | Male | 8 | 2019 | 55663 | 0.050 |
Why?
| | Marijuana Abuse | 1 | 2005 | 212 | 0.050 |
Why?
| | Retrospective Studies | 4 | 2022 | 12544 | 0.050 |
Why?
| | Contrast Media | 2 | 2015 | 353 | 0.050 |
Why?
| | Disease Management | 2 | 2016 | 563 | 0.050 |
Why?
| | Echocardiography, Transesophageal | 1 | 2022 | 89 | 0.050 |
Why?
| | Ventricular Function, Right | 1 | 2023 | 252 | 0.050 |
Why?
| | Cardiac Catheterization | 1 | 2023 | 535 | 0.040 |
Why?
| | Bolivia | 1 | 2019 | 62 | 0.040 |
Why?
| | California | 1 | 2019 | 363 | 0.040 |
Why?
| | Opioid-Related Disorders | 1 | 2005 | 413 | 0.040 |
Why?
| | Shear Strength | 1 | 2018 | 65 | 0.040 |
Why?
| | Pulmonary Artery | 1 | 2023 | 1028 | 0.040 |
Why?
| | Aged | 4 | 2019 | 19122 | 0.040 |
Why?
| | Stents | 1 | 2021 | 476 | 0.040 |
Why?
| | Blood Flow Velocity | 1 | 2018 | 387 | 0.030 |
Why?
| | Stress, Mechanical | 1 | 2018 | 447 | 0.030 |
Why?
| | Heart Septum | 1 | 2016 | 26 | 0.030 |
Why?
| | Penetrance | 1 | 2016 | 27 | 0.030 |
Why?
| | Genes, Dominant | 1 | 2016 | 94 | 0.030 |
Why?
| | Mycobacterium chelonae | 1 | 2016 | 8 | 0.030 |
Why?
| | Membranes | 1 | 2015 | 18 | 0.030 |
Why?
| | Sympathomimetics | 1 | 2015 | 25 | 0.030 |
Why?
| | Colorado | 2 | 2015 | 4091 | 0.030 |
Why?
| | Sarcomeres | 1 | 2016 | 90 | 0.030 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2016 | 38 | 0.030 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2016 | 26 | 0.030 |
Why?
| | Risk | 1 | 2018 | 815 | 0.030 |
Why?
| | Injections, Intramuscular | 1 | 2015 | 118 | 0.030 |
Why?
| | Mycobacterium avium Complex | 1 | 2016 | 92 | 0.030 |
Why?
| | Radiology Information Systems | 1 | 2015 | 29 | 0.030 |
Why?
| | Atrophy | 2 | 2005 | 151 | 0.030 |
Why?
| | Preoperative Care | 1 | 2017 | 317 | 0.030 |
Why?
| | Child | 3 | 2018 | 18366 | 0.030 |
Why?
| | Calcinosis | 1 | 2017 | 242 | 0.030 |
Why?
| | Muscle Proteins | 1 | 2016 | 210 | 0.030 |
Why?
| | Efficiency, Organizational | 1 | 2015 | 126 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2016 | 524 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2016 | 345 | 0.030 |
Why?
| | Workload | 1 | 2015 | 132 | 0.030 |
Why?
| | Hemodynamics | 1 | 2018 | 1014 | 0.030 |
Why?
| | Genetic Testing | 1 | 2016 | 379 | 0.030 |
Why?
| | Texas | 1 | 2013 | 188 | 0.030 |
Why?
| | Adolescent | 3 | 2018 | 17829 | 0.030 |
Why?
| | Electrocardiography | 1 | 2015 | 562 | 0.030 |
Why?
| | Fetal Diseases | 1 | 2013 | 147 | 0.030 |
Why?
| | Convection | 1 | 2012 | 7 | 0.030 |
Why?
| | Educational Measurement | 1 | 2013 | 257 | 0.020 |
Why?
| | Tumor Burden | 1 | 2012 | 262 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2018 | 3008 | 0.020 |
Why?
| | Liposomes | 1 | 2012 | 146 | 0.020 |
Why?
| | Middle Aged | 3 | 2017 | 26806 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2012 | 706 | 0.020 |
Why?
| | Funnel Chest | 1 | 2009 | 20 | 0.020 |
Why?
| | Disease Progression | 1 | 2016 | 2392 | 0.020 |
Why?
| | Joint Dislocations | 1 | 2009 | 56 | 0.020 |
Why?
| | Young Adult | 2 | 2017 | 10478 | 0.020 |
Why?
| | Nanoparticles | 1 | 2012 | 313 | 0.020 |
Why?
| | Pregnancy | 2 | 2013 | 5527 | 0.020 |
Why?
| | Arthritis | 1 | 2009 | 111 | 0.020 |
Why?
| | Risk Assessment | 1 | 2017 | 2975 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 4407 | 0.020 |
Why?
| | Osteomyelitis | 1 | 2009 | 102 | 0.020 |
Why?
| | Efficiency | 1 | 2007 | 84 | 0.020 |
Why?
| | Bone Neoplasms | 1 | 2009 | 194 | 0.020 |
Why?
| | Research Support as Topic | 1 | 2007 | 108 | 0.020 |
Why?
| | Personnel Selection | 1 | 2007 | 63 | 0.020 |
Why?
| | Cohort Studies | 1 | 2016 | 4903 | 0.020 |
Why?
| | Toluene | 1 | 2005 | 11 | 0.020 |
Why?
| | Infant | 1 | 2018 | 7937 | 0.020 |
Why?
| | Child, Preschool | 1 | 2018 | 9086 | 0.010 |
Why?
| | Prospective Studies | 1 | 2016 | 6218 | 0.010 |
Why?
| | Research | 1 | 2007 | 395 | 0.010 |
Why?
| | Fractures, Bone | 1 | 2009 | 367 | 0.010 |
Why?
| | Rats | 1 | 2012 | 4963 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 2005 | 642 | 0.010 |
Why?
| | Heart Failure | 1 | 2016 | 1952 | 0.010 |
Why?
| | United States | 1 | 2007 | 12211 | 0.010 |
Why?
| | Animals | 1 | 2012 | 31839 | 0.010 |
Why?
|
|
Vargas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|